Genprex, Inc. short interest in 2022
In 2022, Genprex, Inc.'s disclosed short interest ran from 9.40% of shares outstanding on 14 Jan 2022 to 3.03% on 30 Dec 2022, a change of -6.37 percentage points. The year's high was 9.40% on 14 Jan 2022 and its low 3.03% on 30 Dec 2022, averaging 4.21% across 24 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 22.41 days on 15 Jul 2022. Full history: Genprex, Inc..
Cite this page
By year: 2020 · 2021 · 2022 · 2023 · 2024 · 2025 · 2026
2022 in figures
- Start of year
- 9.40% (14 Jan 2022)
- End of year
- 3.03% (30 Dec 2022)
- Change
- -6.37 pp
- High
- 9.40% (14 Jan 2022)
- Low
- 3.03% (30 Dec 2022)
- Average
- 4.21%
- Highest days to cover
- 22.41 (15 Jul 2022)
- SEC filings marked
- 4
Every report in 2022
| Settlement | Short interest | Days to cover | Filings since previous |
|---|---|---|---|
| 14 Jan 2022 | 9.40% | 1.00 | |
| 31 Jan 2022 | 7.16% | 1.72 | |
| 15 Feb 2022 | 6.22% | 5.35 | |
| 28 Feb 2022 | 5.01% | 4.90 | |
| 15 Mar 2022 | 4.00% | 3.87 | |
| 31 Mar 2022 | 3.88% | 5.63 | 10-K filed |
| 14 Apr 2022 | 4.19% | 11.03 | |
| 29 Apr 2022 | 4.08% | 10.14 | |
| 13 May 2022 | 4.03% | 12.64 | 10-Q filed |
| 31 May 2022 | 4.25% | 17.02 | |
| 15 Jun 2022 | 3.83% | 15.72 | |
| 30 Jun 2022 | 3.91% | 20.79 | |
| 15 Jul 2022 | 3.94% | 22.41 | |
| 29 Jul 2022 | 3.49% | 20.53 | |
| 15 Aug 2022 | 3.34% | 6.14 | 10-Q filed |
| 31 Aug 2022 | 3.88% | 2.34 | |
| 15 Sep 2022 | 3.66% | 13.12 | |
| 30 Sep 2022 | 3.64% | 14.45 | |
| 14 Oct 2022 | 3.35% | 11.02 | |
| 31 Oct 2022 | 3.29% | 18.38 | |
| 15 Nov 2022 | 3.22% | 22.04 | 10-Q filed |
| 30 Nov 2022 | 3.24% | 20.90 | |
| 15 Dec 2022 | 3.10% | 12.99 | |
| 30 Dec 2022 | 3.03% | 5.97 |
See also: Genprex, Inc.'s full history · most shorted US stocks of 2022 · today's US league.
About this data
US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.